Drug Type Small molecule drug |
Synonyms- |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Amyotrophic Lateral Sclerosis | Phase 2 | Sweden | 15 Jul 2022 | |
| Brain Injuries, Traumatic | Phase 2 | Sweden | 15 Jul 2022 | |
| Glaucoma | Phase 2 | Sweden | 15 Jul 2022 | |
| Stroke | Phase 2 | Sweden | 15 Jul 2022 | |
| Dengue | Preclinical | Sweden | 01 Oct 2026 | |
| Limb ischemia | Preclinical | Sweden | 01 Oct 2026 | |
| Yellow Fever | Preclinical | Sweden | 01 Oct 2026 | |
| Zika Virus Infection | Preclinical | Sweden | 01 Oct 2026 | |
| Alzheimer Disease | Preclinical | Sweden | - | |
| Cicatrix | Preclinical | Sweden | - |





